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Abstract: Lipids from the proliferative macroalgae Ulva armoricana (Chlorophyta) and 
Solieria chordalis (Rhodophyta) from Brittany, France, were investigated. The total content 
of lipids was 2.6% and 3.0% dry weight for U. armoricana and S. chordalis, respectively. 
The main fractions of S. chordalis were neutral lipids (37%) and glycolipids (38%), whereas 
U. armoricana contained mostly neutral lipids (55%). Polyunsaturated fatty acids (PUFA) 
represented 29% and 15% of the total lipids in U. armoricana and S. chordalis, respectively. 
In both studied algae, the phospholipids were composed of PUFA for 18%. In addition, PUFA 
were shown to represent 9% and 4.5% of glycolipids in U. armoricana and S. chordalis, 
respectively. The essential PUFA were 16:4n-3, 18:4n-3, 18:2n-3, 18:2n-6, and 22:6n-3 in 
U. armoricana, and 20:4n-6 and 20:5n-3 in S. chordalis. It is important to notice that six  
2-hydroxy-, three 3-hydroxy-, and two monounsaturated hydroxy fatty acids were also 
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identified and may provide a chemotaxonomic basis for algae. These seaweeds contained 
interesting compounds such as squalene, α-tocopherol, cholest-4-en-3-one and phytosterols. 
The antiproliferative effect was evaluated in vitro on human non-small-cell bronchopulmonary 
carcinoma line (NSCLC-N6) with an IC50 of 23 μg/mL for monogalactosyldiacylglycerols 
isolated from S. chordalis and 24 μg/mL for digalactosyldiacylglycerols from U. armoricana. 
These results confirm the potentialities of valorization of these two species in the fields of 
health, nutrition and chemotaxonomy. 
Keywords: Ulva armoricana; Solieria chordalis; fatty acids; sterols; phospholipids; glycolipids; 
polyunsaturated fatty acids; hydroxy fatty acids; chemotaxonomy; human lung cancer 
 
1. Introduction 
Seaweeds are known for their richness in nutritionally beneficial components and contain bioactive 
compounds such as proteins, carbohydrates, antioxidants, minerals, dietary fibers, vitamins and 
polyunsaturated fatty acids (PUFAs) [1]. 
In recent years, lipid composition in marine algae has raised considerable interest due to their high 
content of PUFAs, specifically α-linolenic (18:3n-3), octadecatetraenoic (18:4n-3), arachidonic (20:4n-6), 
and eicosapentaenoic acids (20:5n-3) [2]. This class of acids was considered as essential nutritional 
components in humans and animals [3]. For example, they play an important role in the prevention of 
cardiovascular diseases, osteoarthritis, diabetes, and it possesses antimicrobial, antiviral, anti-inflammatory 
and antitumoral properties [2,3]. 
Furthermore, studies dealing with fatty acids (FA) of seaweeds are also interesting for the usefulness 
of FA as potential chemotaxonomic biomarkers. Their lipid profiles could assist the assignment of algal 
taxonomic position and provide signature profiles for use in organic geochemistry and food studies [4]. 
Such biochemical analysis may also be useful to study the abundance and ecology of these species in 
the marine environments. 
An attractive approach to find sources of marine lipids, could be the exploitation of coastal proliferative 
seaweeds species especially if they contain interesting substances. This is the case for Solieria chordalis 
(Rhodophyta) and for Ulva armoricana (Chlorophyta), which are proliferative species found in Brittany 
(North West of France). 
Thus, the present study explores the lipid composition of S. chordalis for the first time and of  
U. armoricana for extending the knowledge on its lipid composition where little is known about FA 
composition of individual lipid classes. The aim is the determination of the potential value of lipid 
composition (total lipid, glycolipid—GL, phospholipids—PL, sterol and unsaponifiable fraction) of 
these proliferative species, which may constitute a nutritional database for chemotaxonomy and  
anti-proliferative activity perspectives. 
So, for these two species, the present study was designed to clarify the content of lipid and glycolipid 
(GL) classes, and the FA composition from total lipids, phospholipids (PL), GL and compounds of 
unsaponifiable fraction. In addition, the GL fractions were evaluated for their anti-proliferative activity 
against human cancer cell lines (non-small cell lung cancer-NSCLC-N6). This present study particularly 
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focuses on lung cancer and to the best of our knowledge for the first time for these species, lung cancer 
being the leading cause of cancer-related mortality in both men and women in the world. 
2. Results and Discussion 
2.1. Lipid Contents and Lipid Classes Distribution 
The specimens of Chlorophyta (Ulva armoricana) and Rhodophyta (Solieria chordalis) used in the 
present investigation were based on their wide distribution and abundance in Brittany (North West of 
France). The total lipid (TL) contents and the lipid class distribution are reported in Table 1. 
Table 1. Total lipid contents (% dry weight) and lipid class distribution (% total lipids) of 
U. armoricana and S. chordalis. 
 U. armoricana (%) S. chordalis (%) 
Water content fresh algae 92.00 ± 1.25 90.05 ± 0.70 
Total lipids 2.62 ± 0.04  2.96 ± 0.04 
Neutral lipids 55.60 ± 0.05  37.70 ± 0.07 
Glycolipids  29.10 ± 0.10  38.50 ± 0.02 
Phospholipids 15.30 ± 0.10  23.70 ± 0.09 
Values are the mean of three replicates (mean (% dw) ± s.d.); s.d., standard deviation. 
The TL content of U. armoricana and S. chordalis was established at 2.62% ± 0.04% dry weight (dw) 
and 2.96% ± 0.04% (dw), respectively. These contents are in agreement with the literature [5,6].  
Table 2 shows the TL contents previously found in various U. armoricana ranging from 0.2% to  
7.9% dw and for Solieria sp. whose levels vary from 0.4% to 2.8%. The values determined in this study 
are higher than those reported for different species of the same genus, as shown in Table 2. Nevertheless, 
it is interesting to note that brown seaweeds generally contain higher TL levels [5]. Furthermore, the TL 
contents of U. armoricana and S. chordalis are lower compared to earth vegetables, such as soy or 
sunflower [6]. 
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Table 2. Total lipid contents of various algal Ulva and Solieria species. 
Phylum Algal Species Location Date 
Reported 
Levels (%) 
References
Chlorophyta 
Ulva sp. 
Beach in Plestin-les-Grèves, France June 2012 0.6% dw [7] 
north-east part of the Black Sea 
(Feodosiya and Karadag Bays, Crimea) 
July 1987 0.2% dw [8] 
U. lactuca 
Coast of Abu Qir Bay near Boughaz  
El-Maadya (Egypt) 
April, August and 
October 2010 
4.0% dw [9] 
Buleji beach of Karachi coast 
Different seasons at 
low tide 
1.2% dw [10] 
Littoral between the area of Téboulba 
and Sayada (Monastir-Tunisia) 
July 2007 7.9% dw [11] 
Chlorophyta 
U. lactuca 
Indian Sundarbans 
September 2007–
June 2008 
0.3%–1.0% dw [12] 
Bohai Sea near Weihai (China) August 1.2% fw [13] 
Bodega Bay, California November 1995 3.1% dw [14] 
Coast of Norway May and June 2012 2.6% dw [15] 
Coast of the Persian Gulf (Iran) - 3.6% dw [16] 
Ria de Aveiro October 2012 0.3% dw [17] 
U. rigida 
north-east part of the Black Sea 
(Feodosiya and Karadag Bays, Crimea) 
July 1987 0.3% dw [8] 
Varvara, Bulgaria October 2011 0.8% fw [18] 
U. fenestrata 
Pacific Ocean in the Northern part  
of Canada 
- 0.5% la [19] 
U. pertusa Bohai Sea near Weihai (China) August 0.9% fw [13] 
U. lactuca  
U. fasciata  
U. taeniata  
U. pertusa  
U. reticulata  
U. beytensis  
U. compressa  
U. rIgida  
U. linza  
U. flexuosa  
U. erecta  
U. prolifera 
Gujarat coast, India March–October 2011 0.7%–2.0% fw [20] 
U. linza Abu Qir Bay, Egypt 
Spring,  
summer,  
autumn 
4.1% dw,  
3.8% dw,  
3.2% dw 
[21] 
Rhodophyta 
S. chordalis 
Littoral zone of the Saint Gildas de 
Rhuys, France 
March 2012 0.9% dw [7] 
S. robusta 
Gujarat coast, India March–October 2011
0.4%–1.0% fw 
0.9% fw 
[20] 
Buleji beach of Karachi coast 
Different seasons at 
low tide 
2.8% dw [10] 
Sea of South China - 0.3% la [19] 
dr, dry weight; fw, fresh weight; la, lyophilized algae. 
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These variations could be related to taxonomic entity, seasonality of sampling, location and macroalgae 
growth conditions [22], in addition to extraction processing and solvent polarity [23]. Sánchez-Machado et al. 
reported that, as the temperature increased, the lipid level decreased and remained almost stable until the 
end of the growing season [24]. In comparison to Grateloupia turuturu (Halymeniaceae), the lipid 
contents are lower, G. turuturu TL content being 3%–4% dw [25]. Each of the TL extracts was fractionated 
into three fractions corresponding to lipid classes (Table 1): neutral lipids (NL—storage lipids), glycolipids 
(GL) and phospholipids (PL—structural lipids). For S. chordalis, the major lipid classes corresponded 
to NL and GL, accounting for 38% each, followed by PL (24%). In the case of U. armoricana, the main 
lipid class was NL with 56%, followed by GL (29%) and by PL (15%). 
2.2. Lipid Composition 
2.2.1. Neutral Lipid and Sterol Composition 
U. armoricana and S. chordalis were examined for their hydrocarbons and sterols present in 
unsaponifiable fractions. The analyses were carried out by gas chromatography coupled to mass 
spectrometry (GC-MS) and observed compositions are given in Table 3. 
Table 3. Composition (%) of the unsaponifiable fractions of U. armoricana and S. chordalis. 
 
U. armoricana (%)  
(21% Total Lipids) 
S. chordalis (%)  
(10% Total Lipids) 
Hydrocarbons 
Hydrocarbons 4.3 ± 0.1 5.7 ± 0.2 
Squalene 2.7 ± 0.1 4.5 ± 0.1 
Total hydrocarbons 7.0 ± 0.1 10.2 ± 0.1 
Sterols 
22(E)-Dehydrocholesterol 1.0 ± 0.1 1.3 ± 0.1 
Cholesterol 35.2 ± 0.3 42.6 ± 0.2 
Campesterol 1.3 ± 0.1 1.7 ± 0.1 
Brassicasterol 3.0 ± 0.2 2.1 ± 0.1 
22-Dehydrolathosterol 0.8 ± 0.1 1.0 ± 0.1 
Fucosterol  1.4 ± 0.1 2.3 ± 0.1 
Isofucosterol 25.0 ± 0.2 nd a 
Cholest-4-en-3-one 0.8 ± 0.1 2.0 ± 0.1 
Total sterols 68.5 ± 0.1 53.0 ± 0.1 
Other compounds 
α-Tocopherol 5.5 ± 0.1 3.1 ± 0.1 
Phytol 19.0 ± 0.1 33.7 ± 0.3 
Values are the mean of three replicates (mean (% dw) ± s.d.); s.d., standard deviation; a nd, not detected. 
Hydrocarbons represented 7% of the unsaponifiable fraction for U. armoricana, among which squalene 
corresponded to 2.7% (Table 3). It is interesting to note that a rich squalene diet enhances anti-tumor 
activity of some chemotherapeutic agents by increasing immune system efficiency and by lowering 
blood cholesterol content [26]. Moreover, there is some evidence that squalene reduces colon cancer and 
skin cancer; this activity likely being related to its antioxidant status [27]. Therefore, squalene may be 
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beneficial in preventive therapy and integrative medicine. Additionally, α-tocopherol represented 5.5% 
of the unsaponifiable fraction from U. armoricana (Table 3), and is an important natural antioxydant [28].  
Moreover, it also contained 19% phytol (Table 3). This particular compound is usually used as a 
precursor for the industrial synthesis of vitamins E and K [29,30]. 
The major constituent of the unsaponifiable fraction from U. armoricana was cholesterol (35%), 
which is one of the main sterols present in seaweeds. Its content in green and brown algae varies from 
2% to 76% of total sterol. In red algae, its content is lower; however, it is still among the major components 
of the sterol fraction [31]. Some green algae, such as Ulva and Chaetomorpha, contain cholesterol or 
28-isofucosterol as their principal sterol [32]. 
Cholest-4-en-3-one was also detected as a minor component for U. armoricana (0.8%, Table 3). This 
compound is a key intermediate in steroid chemistry, which is known as a cholesterol derivative occurring 
in both plant and animal tissues [33]. It may result from the biosynthesis or the autoxidation of cholesterol. 
Cholest-4-en-3-one, known as an intestinal catabolite of cholesterol, has an anti-obesity effect on  
animals [34]. 
Finally, the unsaponifiable fraction of U. armoricana also contained other phytosterols. They 
corresponded to campesterol, brassicasterol, isofucosterol, which are known to exhibit cholesterol-lowering 
effects by decreasing intestinal cholesterol absorption [35]. Furthermore, the activity of phytosterols on 
cardiovascular diseases and their potent anti-inflammatory properties have been reported [35]. For 
Humans, all phytosterols come from dietary sources, as Humans cannot de novo synthesize phytosterols. 
Aknin et al. have investigated sterol composition of three Chlorophyceae orders and showed that 
sterol composition offers distinguishing features for the chemotaxonomic classification of these algae [36]. 
Isofucosterol is typical for Ulotrichales and particularly the Ulvaceae family. Nobuo et al. have also 
found that the sterol content in marine Chlorophyta is similar to higher plants [37]. 
Regarding S. chordalis, hydrocarbons represented 10.2% of the unsaponifiable fraction, among which 
squalene corresponded to 4.5%. Furthermore, α-tocopherol and phytol were also detected and represented 
3.1% and 34% of the unsaponifiable fraction, respectively. The main component of the unsaponifiable 
fraction was cholesterol (43%). Other minor sterols were detected such as cholest-4-en-3-one, but no 
isofucosterol was detected (Table 3). 
Our results about sterols composition of S. chordalis (Gigartinales) showed differences with  
the results of Nasir et al. who identified 22-dehydrocholesterol, cholesterol and stigmasterol from 
Gracilaria salicornia (Gigartinales), and 22-dehydrocholesterol, cholesterol, cholesterol oleate, and 
(22E)-cholesta-5,22-dien-3β-ol-7-one from Hypnea flagelliformis (Gigartinales) [38]. 
2.2.2. Fatty Acid Composition of Total Lipids 
All fatty acids (FAs) of the TL were converted into the fatty acid methyl esters (FAMEs) by 
transmethylation with methanolic hydrogen chloride. The FAs were identified as FAME by comparing 
their equivalent chain lengths (ECLs) values with those previously described or by using commercial 
mixtures. The ECLs of the FAMEs were determined by expressing their elution positions relative to 
those of known straight-chain saturated FAMEs. 
FAMEs were converted to N-acyl pyrrolidides (NAPs) in order to locate double bonds and  
branching [28]. The FA composition of TL is given in Table 4. 
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Table 4. Fatty acid (% of the total FAs mixture) of U. armoricana and S. chordalis. 
Fatty Acid (FAs) a ECL c U. armoricana (%) S. chordalis (%) 
Saturated fatty acids (SFAs) 
14:0 14.00 0.6 ± 0.2 2.6 ± 0.2 
15:0 15.00 0.4 ± 0.1 1.4 ± 0.1 
16:0 16.00 42.0 ± 0.2 45.0 ± 0.2 
18:0 18.00 1.0 ± 0.1 9.9 ± 0.1 
22:0 22.00 2.3 ± 0.1 nd b 
24:0 24.00 0.2 ± 0.1 nd b 
Total SFAs  46.5 ± 0.1 58.9 ± 0.1 
Monounsaturated fatty acids (MUFAs) 
14:1 13.63 0.4 ± 0.1 nd b 
15:1 14.57 nd b 0.2 ± 0.1 
16:1n-9 15.79 2.7 ± 0.1 nd b 
16:1n-7 15.94 1.9 ± 0.1 nd b 
16:1 15.76 nd b 0.2 ± 0.1 
17:1n-7 16.77 nd b 18.5 ± 0.1 
18:1 17.14 1.9 ± 0.1 nd b 
18:1n-9 17.71 nd b 3.4 ± 0.1 
18:1n-7 17.78 17.3 ± 0.1 4.0 ± 0.1 
Total MUFAs  24.3 ± 0.1 26.3 ± 0.1 
Polyunsaturated fatty acids (PUFAs) 
14:2 13.53 1.6 ± 0.1 nd b 
16:4n-3  15.61 6.4 ± 0.1 nd b 
18:4n-3 17.70 8.6 ± 0.1 nd b 
18:3n-3 17.77 0.5 ± 0.1 nd b 
18:2n-6 17.80 3.7 ± 0.1 nd b 
18:2n-3 17.87 8.4 ± 0.1 nd b 
20:5n-3 19.21 Trace 5.0 ± 0.1 
20:4n-6 19.33 Trace 9.8 ± 0.1 
Total PUFAs  29.2 ± 0.1 14.8 ± 0.1 
Total n-6 PUFAs  3.7 ± 0.1 9.8 ± 0.1 
Total n-3 PUFAs  23.9 ± 0.1 5.0 ± 0.1 
Ratio n-6/n-3  0.1 ± 0.1 1.9 ± 0.1 
a Methyl ester (%) of total FA of total FA mixture; b nd, not detected; c ECLs, equivalent chain lengths;  
Minor FA (≤0.1%), Docosenoic (22:1); Values are the mean of three replicates (mean (% dw) ± s.d.); s.d.,  
standard deviation. 
The saturated fatty acids (SFAs) corresponded to 46.5% and 58.9% of TL from U. armoricana and 
S. chordalis, respectively. Their chain length ranged from C14 to C24 for U. armoricana and from C14 to 
C18 for S. chordalis. In the case of U. armoricana, the major SFAs were palmitic acid (42%) and behenic 
acid (2.3%). For S. chordalis, the major SFA were palmitic acid (45%) and stearic acid (10%). 
Monounsaturated FAs (MUFAs) contents were 24.3% for U. armoricana and 26.3% for S. chordalis. 
The predominant MUFAs were 16:1n-9 (2.7%) and 18:1n-7 (17.3%) for U. armoricana, and were  
17:1n-7 (18.5%), 18:1n-7 (4%) and 18:1n-9 (3.4%) for S. chordalis. 
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PUFAs corresponded to 29.2% and 14.8% of the TL composition of U. armoricana and S. chordalis, 
respectively. The main PUFAs observed in U. armoricana TL were 16:4n-3 (6.4%), 18:4n-3 (8.6%), 
18:2n-6 (3.7%) and 18:2n-3 (8.4%), with traces of arachidonic 20:4n-6 (AA), eicosapentaenoic 20:5n-3 
(EPA), and docosahexaenoic 22:6n-3 (DHA) acids. In the case of S. chordalis, 20:4n-6 (9.8%) and 
20:5n-3 (5%) acids were the major PUFAs. 
These results are in agreement with the literature concerning seaweeds. Red seaweed species contain 
significant quantities of PUFA, up to 20 carbons, with four or five double bonds. Their two major PUFAs 
are AA and EPA. In addition, a high C20/C18 PUFA ratio is observed with high C18:1 content [20]. Green 
seaweeds are characterized by C16 and C18 PUFA with a high C18/C20 PUFA ratio [14]. 
According to the literature, palmitic acid (16:0) is predominant in seaweeds [39]. As in the vegetative 
tissues of higher plants, the green algae contain primarily C16 and C18 fatty acids with a high degree of 
unsaturation [32]. The amount of 16:4n-3 varies from 4.9% to 23.4%, which is characteristic of green 
algae in addition with the presence of 16:3 [40]. Unlike red and brown algae, green algae contain large 
amounts of 16:3 and 16:4 PUFAs [40]. Johns et al. have proposed that 16:4 can be taxonomically 
characteristic of green macrophytic algae [41], as in plants of other divisions, it is only found in trace 
amount. Green algae are characterized by high contents of 18:2 and 18:3, like in land plants, U. armoricana 
being very rich in C18 PUFAs [13,42]. Linoleic acid (18:2n-6) is the main PUFA of most  
chlorophytes [13,14] and the α-linolenic acid (18:3n-3) is characteristic of the Ulvales [13,14]. 
Furthermore, marine algae also contain the n-3 PUFAs. The n-3 long-chain PUFAs are abundant in 
most red algae, and this is similar for the n-6 long-chain PUFAs and 18:4n-3 [43]. 
In comparison with other species, the FA profiles obtained for S. chordalis were consistent with those 
reported in previous studies [13,19,20,22,25,43,44]. 
According to the literature, the PUFAs 20:4n-6 and 20:5n-3 are predominant in marine red algae, 
such as S. robusta and S. chordalis [13]. Furthermore, according to Aknin et al. [44] who reported the 
FAs composition of five Solieriaceae, almost 40 fatty acids were identified, the major fatty acids  
being 16:0, 16:1n-5, 4-OH-3,5-diiodo phenyl (dihydrohydnocarpic), 18:1n-9, 18:1n-7, 14:0, 
dihydrochaulmoogric, 18:1n-5, 20:4n-6 and 20:5n-3. 
Although U. armoricana and S. chordalis displayed high amounts of SFA, the contents of PUFAs 
ranged from 14.8% to 29.2%. It confirms that seaweeds contain significantly higher levels of PUFAs 
than land vegetables [6]. Interestingly, marine algae are rich in PUFA of the ω3 and ω6 series, which 
are considered essential FA. The World Health Organization currently recommends that the n-6/n-3 ratio 
should not exceed 10 in a diet [45]. Therefore, U. armoricana and S. chordalis may be used for the 
reduction of the n-6/n-3 ratio, as in TL, the n-3 PUFA of U. armoricana (23.9%) is higher than the n-6 
PUFA (3.7%) and the n-3 PUFA of S. chordalis (5%) is lower than the n-6 PUFA (9.8%). The n-6/n-3 
ratio was established at 0.1 for U. armoricana and 1.9 for S. chordalis. 
In addition, the benefits of PUFAs in human health are well documented, including cardiovascular  
effects [46]. Particularly, the n-3 PUFA may be beneficial for the prevention of several types of cancer, 
and exhibits various biological activities such as decrease of blood pressure and improvement of heart and 
liver function in body fat in animal trials [47]. Generally, the marine n-3 PUFAs exert anti-arteriosclerosis, 
anti-hypertensive, anti-inflammatory, immune-regulatory, antioxidant and anti-thrombotic effects, and 
antiarrhythmic responses [48]. In addition, they are precursors of the eicosanoids biosynthesis, which 
are bioregulators in many cellular processes [39]. The impact of n-3 PUFAs on brain function and mental 
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health has also been recently examined, showing that they are able to improve the mitochondrial  
function [49]. Both AA and EPA are precursors of prostaglandins, thromboxane and other eicosanoids, 
which influence inflammation processes and immune reactions [47]. Linoleic acid, linolenic acid and 
arachidonic acid serve important functions in skin growth and protection. Finally, 20:4n-6, 20:5n-3, and 
20:3n-6 lipids have valuable biological activities such as heart and mental health, arthritis, cancer and 
lung disease [13]. 
2.2.3. Fatty Acid Composition of Phospholipids 
The PL FAs of U. armoricana and S. chordalis were identified by GC-MS analyses as FAMEs and 
N-acyl pyrrolidides (NAPs) as previously described for FAs of the TL. For many FAs, GC-MS data of 
the NAP derivatives allowed us to confirm their structures and to determine the location of double bonds, 
branching and hydroxyl groups [50].  
More than 35 FAs were identified in PL of U. armoricana and 19 FAs in PL of S. chordalis as showed 
in Table 5. 
Table 5. Fatty acid (% of the phospholipids FAs mixture) of U. armoricana and S. chordalis. 
Fatty Acid (FAs) a ECL c U. armoricana (%) S. chordalis (%) 
Saturated fatty acids (SFAs) 
13:0 13.00 1.7 ± 0.2 nd b 
14:0 14.00 0.9 ± 0.1 2.3 ± 0.1 
15:0 15.00 0.2 ± 0.2 0.4 ± 0.1 
16:0 16.00 53.6 ± 0.1 29.0 ± 0.1 
17:0 17.00 0.4 ± 0.1 0.8 ± 0.1 
18:0 18.00 4.6 ± 0.1 5.0 ± 0.1 
19:0 19.00 0.2 ± 0.0 nd b 
20:0 20.00 0.3 ± 0.1 nd b 
21:0 21.00 0.2 ± 0.0 nd b 
22:0 22.00 1.9 ± 0.2 nd b 
24:0 24.00 0.3 ± 0.1 nd b 
Total SFAs  64.3 ± 0.1 37.5 ± 0.1 
Monounsaturated fatty acids (MUFAs) 
15:1 14.57 0.2 ± 0.1 nd b 
16:1n-11 15.70 1.7 ± 0.1 nd b 
16:1n-8 15.85 nd b 3.0 ± 0.1 
16:1n-7 15.94 1.2 ± 0.1 nd b 
17:1n-14 16.73 3.6 ± 0.1 nd b 
17:1n-7 16.77 nd b 8.6 ± 0.1 
17:1n-4 16.88 nd b 10.2 ± 0.2 
18:1n-9 17.71 nd b 2.2 ± 0.2 
18:1n-7 17.78 5.8 ± 0.1 3.2 ± 0.1 
18:1n-3 17.96 nd b 9.6 ± 0.1 
19:1 18.54 0.5 ± 0.2 nd b 
22:1 21.60 0.4 ± 0.1 nd b 
Total MUFAs  13.4 ± 0.1 36.8 ± 0.1 
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Table 5. Cont. 
Polyunsaturated fatty acids (PUFAs) 
16:4n-3 15.60 2.2 ± 0.1 nd b 
18:4n-3 17.70 3.3 ± 0.1 nd b 
18:3 17.75 nd b 1.2 ± 0.2 
18:3n-3 17.77 7.6 ± 0.2 nd b 
18:2 17.79 nd b 2.1 ± 0.1 
18:2n-6 17.80 1.7 ± 0.2 nd b 
20:5n-3 19.21 0.4 ± 0.1 2.6 ± 0.1 
20:4n-6 19.32 0.4 ± 0.1 12.2 ± 0.1 
20:3n-9 19.44 0.4 ±0.1 nd b 
20:2 19.56 0.4 ± 0.1 nd b 
21:3 20.64 0.4 ± 0.1 nd b 
22:6n-3 21.54 0.3 ± 0.1 nd b 
22:5 21.63 0.8 ± 0.1 nd b 
22:3 21.83 0.6 ± 0.1 nd b 
Total PUFAs  18.5 ± 0.1 18.1 ± 0.1 
Hydroxy fatty acids (Hydroxy FAs) 
2-Hydroxy FAs    
2-OH-16:1 17.18 nd b 1.5 ± 0.1 
2-OH-16:0 17.31 1.0 ± 0.1 1.4 ± 0.1 
2-OH-17:0 18.26 0.2 ± 0.1 4.5 ± 0.1 
2-OH-18:0 19.24 1.0 ± 0.1 nd b 
2-OH-22:0 23.26 0.1± 0.1 nd b 
3-Hydroxy FAs    
3-OH-17:1 18.53 0.2± 0.1 nd b 
Total Hydroxy FAs  2.5 ± 0.1 7.4 ± 0.1 
Total Fatty aldehyde   1.3 ± 0.1 nd b 
dimethylacetals    
Total n-6 PUFAs  2.1 ± 0.1 12.2 ± 0.1 
Total n-3 PUFAs  13.8 ± 0.1 12.2 ± 0.1 
Ratio n-6/n-3  0.1 ± 0.1 1.0 ± 0.1 
a Methyl ester (%) of total FA of total FA of total PL; b nd, not detected; c ECLs, equivalent chain lengths; 
Values are the mean of three replicates (mean (% dw) ± s.d.); s.d., standard deviation. 
The SFAs represented 64.3% and 37.5% of the PL from U. armoricana and S. chordalis, respectively. 
They ranged from C13 to C24 for U. armoricana and from C14 to C18 for S. chordalis. The major SFAs 
for U. armoricana were palmitic acid (53.6%), and stearic acid (4.6%). For S. chordalis, the main SFAs 
were myristic acid (2.3%), palmitic acid (29%) and stearic acid (5%). 
MUFAs content represented 13.4% and 36.8% of PL fraction for U. armoricana and S. chordalis, 
respectively. The main MUFAs of U. armoricana were 17:1n-14 (3.6%) and 18:1n-7 (5.8%). In the case 
of S. chordalis, the major MUFAs were 16:1n-8 (3%), 17:1n-7 (8.6%), 17:1n-4 (10.2%), 18:1n-7 (3.2%) 
and 18:1n-3 (9.6%). 
PUFAs content of the PL fraction corresponded to 18.5% and 18.1% for U. armoricana and  
S. chordalis, respectively. The main PUFAs in U. armoricana PL were 16:4n-3 (2%), 18:4n-3 (3.3%), 
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18:3n-3 (7.6%) and 18:2n-6 (1.7%). In addition, AA, EPA, and DHA acids were also detected as minor 
constituents. In the case of S. chordalis, 20:4n-6 and 20:5n-3 acids were the major PUFAs (12.2% and 
3%, respectively). Their contents are higher than in edible red seaweeds such as Chondrus crispus or 
Gracilaria verrucosa and commercial fish oils [22]. 
Regarding the n-6/n-3 ratio, it was established at 0.1 for U. armoricana and 1 for S. chordalis. Five 
hydroxy FAs were identified in PL of U. armoricana representing 2.5%, including four 2-hydroxy FA 
(C16–C22) and one monounsaturated 3-hydroxy FA (C17). Three hydroxy FA were identified in PL of S. 
chordalis corresponding to 7.4%, including 2-hydroxy FA (C16–C17), whose one monounsaturated  
2-hydroxy acids (C16) (Table 5). To our knowledge, these two monounsaturated 2-hydroxy and  
3-hydroxy FA are reported in seaweeds for the first time. 
All the spectra of the 2-hydroxy FAME exhibited molecular ions and other diagnostic fragment ions 
such as the ions at m/z 90 arising from the McLafferty rearrangement (instead of the usual m/z 74 for 
FAME) and m/z 103, the ion [M-MeOH]+, and a relatively intense [M-COOMe]+ ion [25,28,50–53]. The 
mass spectra of their NAP derivatives showed the molecular ion peak and prominent peaks at m/z 98 
and 100, and a base peak at m/z 129 (McLafferty, 113 + 16). 3-Hydroxy FA was identified since the 
mass spectra of methyl esters and NAP derivatives showed base peaks at m/z 103 and 142,  
respectively [28,52]. 
The 2- and 3-hydroxy FA are only minor constituents of PL FA but they are ubiquitous in nature. 
They have been reported in marine sponge lipids, which is a marine organism that has bacterial  
symbiosis [50,51], and in the red algae Schizymenia dubyi (Gigartinales) [52] and G. turuturu 
(Halymeniales) [53]. Matsumoto et al. reported that 3- and 2-hydroxy FA in microalgae may be used to 
classify algal species [54]. Bacteria are also recognized as an important source of the hydroxy FA in the 
natural environment [55], and the 2-hydroxy FA are known to occur in sulfate-reducing bacteria [56]. Several 
short-chains 3-hydroxy FA were reported as antifungal substances [57], demonstrating that 2- and  
3-hydroxy FA are able to influence the membrane properties. For instance, at lower temperatures, some 
bacteria modify their membranous fatty acid composition by increasing the amount of 2- and 3-hydroxy FA 
for maintaining the functional homeoviscous state of their membrane [19]. Moreover, there are several 
examples of close associations between bacteria and algae [58,59]. 
In addition, it is the first time that monounsaturated 3-hydroxy C17 was identified in U. armoricana. 
Until now, the 3-hydroxy short-chain acids were known as typical bacterial FA. Thus, this hydroxy FA 
identified in U. armoricana could be of symbiotic origin. 
Furthermore, unidentified aldehyde dimethylacetals (DMA), were detected at trace levels in the FA 
of PL of U. armoricana. Their mass spectra displaying the characteristic fragment ion m/z 75  
([(CH3O)2-CH]+) as the base peak [51]. DMA revealed the presence of particular PL named plasmalogens 
known for various biological properties probably including protection against oxidation [60]. Such 
compounds have been reported from sponges and mollusks [51], and, very recently, in our previous 
study performed on G. turuturu [25]. 
In addition, variations in the FA composition can be attributed to environmental conditions, habitat, 
light, salinity, pollution, species and genetic status, location and seasonality, geography of development of 
the seaweed and to the method used for extracting oil [43]. Some recent investigations have demonstrated 
that FA profiles were specific to taxonomic groups [20,43,61,62]. Al-Hasan et al. have reported 
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variations in macroalgae FA concentrations, but not in the composition pattern when the temperature 
varied [63]. According to Hotimchenko, light conditions influence the FA lipid contents and ratios [64]. 
In red seaweed, phosphatidylcholine and phosphatidylglycerol have been reported to be the major 
polar phospholipids, besides minor phosphatidylethanolamine, diphosphatidylglycerol and unidentified 
compounds [65]. 
2.2.4. Fatty Acid Composition of Glycolipids 
Glycolipids of S. chordalis were the main lipid group and the second for U. armoricana. The 
glycolipid composition from the two algae was analyzed by thin layer chromatography (TLC), as shown 
in Table 6. Both U. armoricana and S. chordalis were composed of monogalactosyldiacylglycerols (MGDG) 
(44% and 44.9%, respectively) digalactosyldiacylglycerols (DGDG) (28.8% and 23%, respectively), and 
sulfoquinovosyl diacylglycerols (SQDG) (27.2% and 32%, respectively). 
Table 6. Glycolipids composition (% wt/wt) of U. armoricana and S. chordalis. 
 U. armoricana S. chordalis
MGDG a 44.0 44.9 
DGDG b 28.8 23.0 
SQDG c 27.2 32.0 
a MGDG, monogalactosyldiacylglycerols; b DGDG, digalactosyldiglycerols; c SQDG, sulfoquinovosyl 
diacylglycerols. 
The GL FAs of U. armoricana and S. chordalis were identified by GC-MS analyses as FAME and 
NAP. The FAs composition of GL is given in Table 7. More than 33 FAs were identified in GL of  
U. armoricana and more than 25 FAs in GL of S. chordalis, as shown in Table 7. 
Table 7. Fatty acid (% of the glycolipids FAs mixture) of U. armoricana and S. chordalis. 
Fatty Acid (FAs) a ECL c U. armoricana b (%) S. chordalis b (%) 
Saturated fatty acids (SFAs) 
12:0 12.00 0.04 nd b 
14:0 14.00 0.6 3.2 
br-15:0 14.46 0.04 nd b 
iso-15:0 14.53 0.08 0.1 
ai-15:0 14.63 0.5 nd b 
15:0 15.00 0.3 0.4 
16:0 16.00 64.2 40.0 
ai-17:0 16.72 0.5 nd b 
17:0 17.00 2.3 5.1 
18:0 18.00 nd b 3.1 
19:0 19.00 1.2 9.9 
20:0 20.00 0.2 0.1 
21:0 21.00 2.4 nd b 
22:0 22.00 2.3 0.1 
23 23.00 0.1 nd b 
24:0 24.00 0.5 0.7 
Total SFAs  75.2 62.7 
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Table 7. Cont. 
Monounsaturated fatty acids (MUFAs) 
13:1 12.72 1.5 nd b 
15:1 14.57 2.5 nd b 
16:1n-5 15.86 nd b 4.1 
16:1n-9 15.79 0.5 nd b 
16:1n-7 15.94 2.1 nd b 
17:1n-5 16.80 nd b 15.4 
17:1n-4 16.88 nd b 0.5 
18:1n-9  17.71 nd b 3.6 
18:1n-7 17.78 3.5 nd b 
18:1n-5 17.84 nd b 1.6 
19:1 18.86 nd b 1.4 
Total MUFAs  10.1 26.6 
Polyunsaturated fatty acids (PUFAs) 
16:4n-3 15.61 2.1 nd b 
18:4n-3 17.70 0.2 nd b 
18:3n-3 17.77 3.5 nd b 
18:2 17.79 nd b 0.2 
18:2n-6 17.80 0.6  nd b 
18:2n-3 17.87  1.8 nd b 
20:5n-3 19.21 nd b 1.2 
20:4n-6 19.32 nd b 2.1 
22:6n-3 21.54  0.9 nd b 
22:3 21.83 nd b 0.9 
Total PUFAs  9.0 4.5 
Hydroxy fatty acids (Hydroxy FAs) 
2-Hydroxy FAs    
2-OH-14:0 15.57 0.04 nd b 
2-OH-16:0 17.30 0.8 0.4 
2-OH-18:0 19.23 0.2 2.7 
2-OH-20:0 21.45 0.4 nd b 
2-OH-22:0 23.26 0.2 0.6 
3-Hydroxy FAs    
3-OH-16:0 17.64 nd b 0.5 
3-OH-17:0 18.55 1.5 0.9 
3-OH-18:0 19.46 0.3 nd b 
Total Hydroxy FAs  3.5 5.1 
Other compounds d  2.2 0.7 
Total n-6 PUFAs  0.6 2.1 
Total n-3 PUFAs  8.5 1.2 
Ratio n-6/n-3  0.07 1.7 
a Methyl ester (%) of the glycolipids FAs mixture; b nd, not detected; c ECLs, equivalent chain lengths; i, iso; 
ai, anteiso; br, branched. Values are the mean of three replicates (mean % dw); d Mass spectra of the compounds 
showed characteristic intense fragment ion at m/z 75. 
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The SFAs represent 75.2% and 62.7% of the GL from U. armoricana and S. chordalis, respectively. 
They ranged from C12 to C24 for U. armoricana and from C14 to C24 for S. chordalis. The major SFA for 
U. armoricana was palmitic acid (64.2%). For S. chordalis, the main SFAs were myristic acid (3.2%), 
palmitic acid (40%), margaric acid (5.1%) and nonadecylic acid (9.9%) (Table 7).  
Four branched-chain FA with short-chains were detected (br-15:0, iso-15:0, ai-15:0, and ai-17:0). 
Branched-chain FAs (iso and anteiso) are typical for the occurrence of bacteria and other  
monomethyl-branched short-chain FAs probably have the same origin [66]. Branched-chain FAs are 
characteristic of gram-positive bacteria [66]. 
MUFAs contents represented 10.1% and 26.6% of GL fraction for U. armoricana and S. chordalis, 
respectively. The main MUFA of U. armoricana were 15:1 (2.5%), 16:1n-7 (2.1%) and 18:1n-7 (3.5%). 
In the case of S. chordalis, the major MUFA were 16:1n-5 (4.1%), 17:1n-5 (15.4%) and 18:1n-9 (3.6%). 
PUFAs content of the GL fraction corresponded to 9% and 4.5% for U. armoricana and S. chordalis, 
respectively. The main PUFAs in U. armoricana GL were 16:4n-3 (2.1%) and 18:3n-3 (3.5%). In 
addition, DHA acid was also detected as minor constituent. In the case of S. chordalis, 20:4n-6 and  
20:5n-3 acids were the major PUFAs (2.1% and 1.2%, respectively). 
Regarding the n-6/n-3 ratio, it was established at 0.07 for U. armoricana and 1.7 for S. chordalis. 
Seven hydroxy FAs were identified in GL of U. armoricana at 2.2%, including five 2-hydroxy FA 
(C14–C22) and two 3-hydroxy FAs (C17–C18). Five hydroxy FA were identified in GL of S. chordalis at 
0.7%, including three 2-hydroxy FA (C16–C12) and two 3-hydroxy acids (C16–C18). Moreover, it is the 
first time that 3-hydroxy short-chain acids were identified in U. armoricana and S. chordalis. Until now, 
the 3-hydroxy short-chain acids were known as typical bacterial FA. Thus, these hydroxy FA identified 
in U. armoricana and S. chordalis could be of symbiotic origin [50,51]. 
2.3. Antiproliferative Activity against Human Non-Small Cell Lung Cancer 
This present study particularly focuses on the valorization of the major glycolipids, such as MGDG 
and DGDG. These lipids are reported to exhibit diverse biological functions, particularly antitumor 
activity, especially those from marine organisms. 
The effect of MGDG and DGDG from U. armoricana and S. chordalis was evaluated for their 
capacity to inhibit in vitro the growth of human tumor cell Lines: NSCLC-N6 cell lines derived from a 
human non-small-cell bronchopulmonary carcinoma (moderately differentiated, rarely keratinized, 
classified as T2N0M0). 
The results showed that only MGDG classes from S. chordalis were active against NSCLC-N6 cell 
lines with IC50 = 23.5 ± 1.3 µg/mL, and 24.0 ± 0.3 μg/mL for DGDG in U. armoricana. 
Silva et al. showed that Ulva rigida and the red macroalga Gelidium microdon Kützing (Gelidiales), 
collected from the Azorean archipelago, exhibited in vitro growth inhibitory effect on human tumor cell 
lines: NCI-H460 (non-small cell lung cancer) [67]. The crude methanol extracts (after removal of 
chlorophylls) of both macroalgae were found moderately active against cell lines (IC50 = 42 µg/mL for 
U. rigida and IC50 = 65 µg/mL for G. microdon). 
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2.4. Proposed Algal Glycolipid Structures of Bioactive Constituents 
To further identify the active constituents of U. armoricana and S. chordalis GL fraction, they were 
profiled by liquid chromatography coupled to high resolution mass spectrometry (HR-MS) [68]. The 
combination of the HR-MS data with the FA composition obtained by GC-MS of the active fraction was 
used to identify compounds responsible of the observed antitumor activity. 
From the U. armoricana, the activity of the DGDG fraction was related to an ion m/z = 887.573 Da 
corresponding to the molecular formula of C47H82O15. This corresponded to a DGDG containing two 
Fas, 14:0 and 18:3n-3 (the major PUFA in DGDG). In the case of S. chordalis MGDG fraction, the 
antitumor activity was related to an ion m/z = 708.399 Da corresponding to the molecular formula of 
C39H62O10, the two FAs branched on the MGDG being 14:0 and 16:1n-5. In both cases the S1 and S2 
position on the glycerol as well as the sugar moiety was undetermined. 
3. Materials and Methods 
3.1. Samples 
Ulva armoricana (Ulvales, Chlorophyceae) was collected on the beach in Plestin-les-Grèves 
(48°39′28″ N, 3°37′47″ W), English Channel (Brittany, France), on 18 June 2012. Solieria chordalis 
(Rhodophyta, Gigartinales, Solieriaceae) was collected in October 2013 from the littoral zone of the 
Saint Gildas de Rhuys (47°30′0″ N, 2°49′60″ W, Atlantic coast, France). The algae were stored, and then 
thoroughly cleaned to remove epiphytes, sediment, organic debris, and macrofauna. Samples were 
successively rinsed with distilled water. The seaweeds were ground to pieces of about 3 mm with a 
hammer mill. The crushed seaweeds were frozen immediately at −25 °C and were thawed at the time of 
lipid analysis. The moisture content (%, MC) of seaweeds was determined by drying 2.00 g of samples 
in a thermo regulated incubator at 105 °C until constant weight and water content was determined 
gravimetrically. MC (%) = (mi − mod/mi) × 100; with mi = initial mass of wet seaweed specimen;  
mod = oven dry mass of seaweed specimen. 
3.2. Lipid Extraction, Lipid Classes, Fatty Acid and Sterol 
Total lipids were extracted from fresh algae crushed (1 kg), with a mixture of chloroform/methanol 
(1:1, v/v) over 2 days at room temperature under agitation for 5 h. The extract was filtered using a Büchner 
funnel and washed with distilled water. The lipid content was determined by the gravimetric method and 
as a percentage of the algae dry weight. 
The proportion of lipid relative to the dry mass corresponds to the weight ratio of the total lipid extract 
and biomass. The percentage (%) of lipid was calculated according to the following equation:  
% Fat = total lipid/(total lipid + dry mass without lipid) × 100. Mass of dry S. chordalis = 71.8 g; Mass 
of lipid content of S. chordalis = 2.2 g; Mass of dry U. armoricana = 88.6 g; Mass of lipid content of  
U. armoricana = 2.4 g. 
One part of lipids (1 g) was fractionated into NL (dichloromethane), GL (acetone) and PL (methanol) 
by normal phase on flash column chromatography (SI-Std, 25 G, 50 μm, 22 bar, 20 mL/mn, IR-50SI/25G, 
Puri Flash® Interchim, Montluçon, France). Fractions were evaporated to dryness and the percentage 
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was determined as percentage of 1 g of lipids. Another part of lipids (50 mg) was saponified with 2 M 
ethanolic potassium hydroxide. A part of the unsaponifiable matter was acetylated using acetic anhydride 
and pyridine giving a mixture containing sterol acetates. The aqueous phase containing potassium salts 
of FA was acidified by 2 M HCl (pH = 4–5) and FA were extracted by dichloromethane. FAMEs were 
prepared by transmethylation (1 h at 80 °C with 6% methanolic hydrogen chloride). A part of these 
FAMEs was heated at 85 °C in a mixture of pyrrolidine and acetic acid for 1 h in order to obtain the  
N-acyl pyrrolidides (NAP). The FAMEs of GL were obtained by acidic methanolysis by heating 10 mg 
of GL with methanol/water/hydrochloric acid (29:4:3, v/v/v, 5 mL) at 80 °C for 18 h. The reaction 
mixture was extracted with water/hexane (3:9, v/v, 12 mL), the organic layer containing the FAME 
mixture was dried on anhydrous sodium sulfate, filtered and weighed after solvent evaporation. A part 
(1/3) of the FAME was preserved; the other was transformed into NAP, as described above. 
Total FAs derivatives, PL FAs derivatives and GL FAs derivatives (FAME and NAP), sterols (as free 
forms and acetates), NL, were analyzed by gas chromatography coupled with mass spectrometry (GC-MS). 
3.3. Thin Layer Chromatography 
Thin layer chromatography (TLC) was carried out for the whole of sterols and glycolipids, in order 
to visualize the families of products. Thin layer chromatography was carried out on a plate of size  
20 cm × 20 cm, consisted of an analytical polyester support and of a silica gel (60F254, 60 Å, 15 µm) of 
0.25 mm thickness. 
The sterols and unsaponifiable fractions composition were studied by TLC in addition to the analysis 
by GC-MS, using hexane, diethyl ether and acetic acid as eluent (85:15:0.1, v/v/v, double elution), with 
a standard cholesterol and cholesterol acetate, phytol, β carotene. Plates were visualized by spraying 
with sulfuric vanillin followed by heating in an oven. 
As to the glycolipid class composition, the mobile phase was dichloromethane/methanol (85:15, v/v, 
double elution). In this case, standards used were monogalactosyldiglycerols (MGDG) (from spinach 
leaves and identified by nuclear magnetic resonance), digalactosyldiglycerols (DGDG), sulfoquinovosyl 
monoacylglycerols (SQMG) and sulfoquinovosyl diacylglycerols (SQDG) purchased from Sigma-Aldrich 
Co. (Saint-Quentin Fallavier, France). Plates were revealed by orcinol/sulfuric acid followed by heating 
in an oven. 
3.4. Gas Chromatography-Mass Spectrometry Analyses of Fatty Acid and Sterol Derivatives 
FAMEs, NAPs, sterols (as free forms and acetates), and neutral lipids were analyzed by GC-MS. The 
samples were analyzed using a Hewlett Packard 6890 series GC system coupled with a MS HP 6890 series, 
equipped with silica capillary column SLB™-5ms (60 m × 0.25 mm × 0.25 µm), the carrier gas was 
helium (1 mL·min−1). The analyses were carried out in electron impact (70 eV). Detector was set at 280 °C, 
and the injector at 250 °C. The samples were injected in splitless mode. Helium was used as the carrier 
gas under a constant flow rate (1 mL/min). Three different temperature gradients were used for FAME 
analysis, as follows: temperature was held at 170 °C for 4 min and programmed to 300 °C at 3 °C·min−1; 
for NAP analysis, 200 °C for 4 min then 3 °C·min−1 up to 310 °C and held for 20 min; and for sterols 
analysis, 200 °C then 3 °C·min−1 to 310 °C and held for 25 min. The solvent delay was 7 min for FAME 
and NAP analyses and 8 min for sterols. 
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The identification of FAs, sterols and unsaponifiable fractions is carried by identification their mass 
spectra. Thus, the FAs were identified as FAMEs by comparing their ECL values with those previously 
described or using commercial mixtures. The ECLs of the FAMEs were determined by expressing their 
elution positions relative to those of known straight-chain saturated FAME. The FAMEs were converted 
to N-acyl pyrrolidides in order to locate double bonds and branching. 
3.5. Cellular Studies (NSCLC-N6) 
The antiproliferative activity of glycolipids of U. armoricana and S. chordalis were evaluated on the 
NSCLC-N6 cell line [69] derived from a human non-small-cell bronchopulmonary carcinoma, moderately 
differentiated, rarely keratinized, classified as T2N0M0. The cell lines were cultured in RPMI 1640 medium 
with 5% fetal calf serum, to which were added 100 IU penicillin·mL−1, 100 mg streptomycin·mL−1 and  
2 mM glutamine, at 37 °C in an air/carbon dioxide atmosphere (95:5, v/v). 
Cytotoxicity was determined by continuous drug exposure. Experiments were performed in 96 wells 
microtiter plates (105 cells·mL−1 for NSCLC-N6). Cell growth was estimated by a colorimetric assay 
based on the conservation of tetrazolium dye (MTT) to a blue formazan product by live mitochondria [70]. 
Eight repeats were performed for each concentration. Control growth was estimated from 8 determinations. 
Optical density at 570 nm corresponding to solubilized formazan was read for each well on a Titertek 
Multiskan MKII. Experiments were performed at least in triplicate, 4 wells per glycolipid concentration 
being used. IC50 values were calculated from the dose-response curves. 
3.6. Liquid Chromatography-Mass Spectrometry Analysis of Glycolipids 
Active GL fractions were analyzed by high performance liquid chromatography coupled with an 
electrospray ionization ion trap time-of-flight multistage mass spectrometer (LCMS-IT-TOF) analyses 
to determine molecular formula. A Shimadzu LCMS-IT-TOF instrument composed of two LC-20ADxr 
pumps, a SIL-20ACxr autosampler, a CTO-20AC column oven, a SPD-M20A DAD detector, a  
CBM-20A system controller, an ESI ion source, and an IT-TOF mass spectrometer (Shimadzu, Kyoto, 
Japan) was used. Chromatographic conditions were adapted from Knittelfelder et al. [68]. LC-MS 
profiles were recorded with a 150 × 2.1 mm, 2.6 µm Kinetex C18 column (Phenomenex) in gradient 
mode at a flow rate of 0.4 mL·min−1 at the temperature of 60 °C. A solvent system composed of (A) 
water/MeOH 1:1 and (B) iso-propanol ; both eluant (A and B) being modified with 0.1% v/v formic acid 
and 10 mM of ammonium formate. The gradient consisted of 5 min at 25% B, followed by an increase 
to 45% B from 5 min to 13 min, followed by an increase to 75.27% B from 13 min to 45 min. The 
column was then washed with 100% iso-propanol for 7 min and re-equilibrated to 25% B for 7 min. 
injection consisted of 2 µL of solution at 1 mg/mL fraction in iso-propanol. The conditions of  
ESI-IT-TOF-MS analyses are listed below: (1) detection mode: positive ion and negative ion; (2) mass 
range: MS, m/z 100–1200 Da; (3) heat block: 250 °C and curved desolvation line temperature: 230 °C; 
nebulizing nitrogen gas flow: 1.5 L/min; interface voltage: (+) 4.0 kV, (−) 3.5 kV; detector voltage of 
the TOF analyzer: 1.61 kV; for MS the ion accumulation time: (+) 20 ms, (−) 5 ms; (4) All data were 
recorded and analyzed by Shimadzu software: LCMS solution Version 3.60, Formula Predictor Version 
1.2, and Accurate Mass Calculator (Shimadzu, Kyoto, Japan); and (5) a trifluoroacetic acid sodium 
solution (2.5 mM) was used to calibrate the mass range from 100 to 1200 Da. 
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3.7. Statistical Analysis 
All measurements were made in triplicate for each alga (n = 3), except for GL analyses,  
which were carried out on only one sample. All data are reported as mean ± standard deviation (SD). 
The statistical analysis was carried out on SPSS v20 (IBM, Chicago, IL, USA) using one-way analysis 
of variance (ANOVA). 
4. Conclusions 
The macroalgae U. armoricana and S. chordalis revealed low lipid contents. However, they exhibited 
high amounts of nutritionally essential n-6 and n-3 PUFAs, including EPA, AA, DHA, 16:4n-3, 18:4n-3, 
18:3n-3, 18:2n-3, and 18:2n-6, but at lower levels than other edible red seaweeds such as Chondrus 
crispus or Gracilaria verrucosa. Therefore, U. armoricana and S. chordalis may be potential sources of 
n-3 and n-6 lipids. The health benefiting n-6/n-3 ratio in macroalgae allows their use in the formulation 
of functional foods and nutraceuticals. In this study, U. armoricana and S. chordalis can be considered 
as a source of dietary PUFAs, since they showed n-6/n-3 ratios ranging from 0.1 for U. armoricana to  
1 for S. chordalis. Moreover, some FAs were identified for the first time in seaweeds as minor 
components such as 3-hydroxyoctadecanoic and the 2-hydroxy acid and two monounsaturated hydroxy 
acids. Hence, FAs compositions may provide a chemotaxonomic basis for macro-algae. These seaweeds 
contained interesting compounds such as phytol (precursor for the industrial synthesis of vitamins E and 
K), α-tocopherol (vitamin E) and squalene. Phytosterols were identified, namely brassicasterol, 
chondrillasterol, fucosterol and isofucosterol. The sterol composition showed also the presence of 
cholest-4-en-3-one. It would be of interest to isolate and identify the most important ones in terms of 
biological activities. Interestingly, glycolipids (MGDG, DGDG and SQDG) from U. armoricana and S. 
chordalis showed promising anti-proliferative activities on cancer cell lines. 
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